Prognostic Validity of the WHO 2010 TNM Staging and Grading Criteria for Pancreatic Neuroendocrine Tumors

#890

Introduction: The TNM staging and grading system developed by the WHO was designed to help prognosticate patients.

Aim(s): To retrospectively stage and grade PNET patients and investigate whether the WHO system offers prognostic relevance.

Materials and methods: One-hundred and three patients with PNETs treated since 2004 were included in this study. Mean age at diagnosis was 57. Median duration of follow-up: 50.3 months.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Mills L, Ramage J, Prachalias A, Srinivasan P, Menon K,

Keywords: neuroendocrine, pancreas, Ki-67, grade,